clenbuterol has been researched along with Convalescence in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Convalescence: The period of recovery following an illness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, PJ | 2 |
| Felkin, LE | 1 |
| Birks, EJ | 2 |
| Cullen, ME | 1 |
| Banner, NR | 2 |
| Grindle, S | 2 |
| Hall, JL | 2 |
| Miller, LW | 2 |
| Yacoub, MH | 2 |
| Latif, N | 1 |
| Hardy, JP | 1 |
| Rider, JE | 1 |
| Khaghani, A | 1 |
2 other studies available for clenbuterol and Convalescence
| Article | Year |
|---|---|
Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Chemokine CX | 2005 |
Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Cardiomyopathies; Cardiovascul | 2005 |